Get Your Personalized Supplement StackSupplement Stack Quiz

Naringin Extract

Q: Is naringin safe to take as a supplement?

Preclinical data suggest naringin is safe, but human data are limited. A significant concern is its potential to interact with medications, particularly those metabolized by the CYP3A4 enzyme.

Q: Can naringin improve liver or kidney health?

Animal studies show significant protective effects on both liver and kidney health, reducing damage and improving function. However, human evidence is currently lacking and requires further research.

Q: Does naringin interact with medications?

Yes, naringin can inhibit CYP3A4, an enzyme that metabolizes many drugs. This can increase drug levels in the body, potentially leading to adverse effects. Consult a healthcare professional if taking medications.

Q: How long does it take to see benefits?

In preclinical studies, effects are typically observed within days to weeks. However, the time frame for benefits in humans is unknown due to the lack of clinical trials.

Q: Is naringin effective for cancer prevention?

Promising preclinical evidence suggests naringin has potential anticancer effects by modulating various pathways. However, clinical confirmation in humans is needed before any definitive claims can be made.

Also known as: Naringin, citrus flavonoid, flavanone glycoside

Overview

Naringin is a bioactive flavanone glycoside predominantly found in grapefruit and other citrus fruits, responsible for their characteristic bitter taste. It is extracted from citrus peel and pulp and is widely recognized for its potent antioxidant, anti-inflammatory, hepatoprotective (liver-protective), and nephroprotective (kidney-protective) properties. Research also suggests its potential in anticancer applications. Naringin exerts its effects by scavenging reactive oxygen species, upregulating endogenous antioxidant enzymes, and modulating inflammatory pathways. While preclinical evidence, including systematic reviews and meta-analyses based on animal studies, is robust and indicates significant benefits, human clinical trials are currently limited. This means that while the mechanisms and effects are well-understood in animal models, the direct applicability and efficacy in humans still require further investigation. It is primarily used as a dietary supplement due to its broad spectrum of beneficial biological activities.

Benefits

Naringin demonstrates significant benefits primarily in preclinical models, with strong evidence for its protective effects on the liver and kidneys. A systematic review and meta-analysis of 20 preclinical studies showed that naringin significantly improved liver function by reducing elevated enzymes (ALT, AST, GGT, LDH, ALP, bilirubin) and enhancing antioxidant enzymes (SOD, catalase, GSH). It also reduced inflammatory cytokines (IL-1β, IL-6, TNF-α) and modulated apoptosis markers, indicating strong hepatoprotective effects. Similarly, a meta-analysis of 27 preclinical studies highlighted naringin's significant nephroprotective effects, alleviating kidney damage through antioxidant, anti-inflammatory, and anti-apoptotic mechanisms. These studies consistently reported statistically significant improvements (p < 0.05 to < 0.001) in biochemical markers and tissue health. Additionally, naringin shows promising secondary effects, including general antioxidant activity by reducing oxidative stress markers and potential anticancer properties by modulating various cancer-related pathways, although these are mainly based on in vitro and animal studies. While the preclinical evidence is compelling, human clinical data are scarce, meaning the clinical significance and population-specific benefits in humans are yet to be established.

How it works

Naringin exerts its beneficial effects primarily through its potent antioxidant and anti-inflammatory properties. It acts by directly scavenging reactive oxygen species (ROS) and reactive nitrogen species (RNS), thereby reducing oxidative stress. Furthermore, it upregulates the activity of endogenous antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione-related enzymes, enhancing the body's natural defense mechanisms. Its anti-inflammatory action involves the downregulation of pro-inflammatory cytokines like IL-1β, IL-6, and TNF-α, and the inhibition of key inflammatory pathways, including NF-κB and COX-2. Naringin also exhibits anti-apoptotic effects by modulating caspase activity and the Bax/Bcl-2 ratio, which helps protect cells from programmed death. While naringin itself is active, it is often metabolized in the gut to naringenin, which is considered more bioavailable and contributes to its systemic effects. These mechanisms collectively contribute to its protective effects on hepatic and renal systems.

Side effects

While preclinical studies suggest naringin is generally well-tolerated at effective doses, human safety data are limited. Common side effects are not well-documented in humans, and animal studies typically show good tolerability. However, a significant concern is naringin's potential for drug interactions. Naringin is known to inhibit cytochrome P450 enzymes, particularly CYP3A4, which is crucial for metabolizing a wide range of medications. This inhibition can lead to increased plasma concentrations of drugs metabolized by CYP3A4, potentially enhancing their effects or increasing the risk of adverse reactions. Medications commonly affected include statins (e.g., simvastatin), calcium channel blockers (e.g., felodipine), and certain immunosuppressants. Therefore, caution is strongly advised for individuals taking any medications, especially those metabolized by CYP3A4. Contraindications include concurrent use with such medications. Specific considerations for pregnant or breastfeeding women, or individuals with pre-existing liver or kidney impairment, are not well-established due to the lack of human clinical data, warranting a cautious approach.

Dosage

Optimal and safe dosage ranges for naringin in humans have not been definitively established due to the limited number of human clinical trials. Preclinical studies utilize variable doses, and human equivalent doses require rigorous clinical validation. Therefore, there is no established minimum effective dose or maximum safe dose for human consumption. Timing considerations for administration are also not established. When considering supplementation, extracts standardized for naringin content are preferred to ensure consistency. While no specific cofactors are required, some research suggests that co-administration with bioavailability enhancers might improve systemic levels, given that naringin is metabolized in the gut to naringenin, which has varying bioavailability. Until robust human clinical data become available, any use of naringin as a supplement should be approached with caution, particularly given its potential for drug interactions.

FAQs

Is naringin safe to take as a supplement?

Preclinical data suggest naringin is safe, but human data are limited. A significant concern is its potential to interact with medications, particularly those metabolized by the CYP3A4 enzyme.

Can naringin improve liver or kidney health?

Animal studies show significant protective effects on both liver and kidney health, reducing damage and improving function. However, human evidence is currently lacking and requires further research.

Does naringin interact with medications?

Yes, naringin can inhibit CYP3A4, an enzyme that metabolizes many drugs. This can increase drug levels in the body, potentially leading to adverse effects. Consult a healthcare professional if taking medications.

How long does it take to see benefits?

In preclinical studies, effects are typically observed within days to weeks. However, the time frame for benefits in humans is unknown due to the lack of clinical trials.

Is naringin effective for cancer prevention?

Promising preclinical evidence suggests naringin has potential anticancer effects by modulating various pathways. However, clinical confirmation in humans is needed before any definitive claims can be made.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/40368365/ – This systematic review and meta-analysis of 20 preclinical studies demonstrated that naringin significantly improved liver function markers, enhanced antioxidant enzymes, and reduced inflammatory cytokines and apoptosis markers in various animal models of liver injury. The findings indicate strong hepatoprotective effects of naringin in preclinical settings.
https://ouci.dntb.gov.ua/en/works/4yo0d259/ – This meta-analysis of 27 preclinical studies revealed that naringin significantly alleviated kidney damage induced by various factors in animal models. The study highlighted naringin's mechanisms, including antioxidant effects via ROS/RNS pathways, anti-inflammatory modulation of key cytokines, and suppression of apoptotic factors, leading to improved kidney structure and function.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8039459/ – This systematic review summarized naringin's potential preventive and therapeutic effects against cancer, primarily based on in vitro and animal studies. It suggested that naringin modulates multiple cancer-related pathways, offering promising but preliminary evidence for its anticancer potential.